2024
DOI: 10.1002/rai2.12101
|View full text |Cite
|
Sign up to set email alerts
|

Advancements in therapeutic paradigm: Harnessing IL‐17A inhibitor secukinumab to ameliorate psoriasis vulgaris in the presence of resistant pericardial effusion

Qing Tan,
Lifeng Xu,
Ruoxi Wu
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 5 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?